BioMarin Pharmaceutical reported for 6 months in 2023

BioMarin Pharmaceutical's GAAP net income for 6 months of 2023 was $106.89 million, down 28% from $148.46 million in the prior year. Revenue increased 13.2% to $1.192 billion against $1.053 billion a year earlier.